<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Wolfson Institute</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CC3D5B5E-CC09-481D-9A5A-37C8351D5735"><gtr:id>CC3D5B5E-CC09-481D-9A5A-37C8351D5735</gtr:id><gtr:firstName>Irwin</gtr:firstName><gtr:surname>Nazareth</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/74075BD3-CF74-4DE5-B86E-D20D2B539139"><gtr:id>74075BD3-CF74-4DE5-B86E-D20D2B539139</gtr:id><gtr:firstName>Joan Katherine</gtr:firstName><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/979F6FB8-AACC-4A25-9F7E-D0E620F050E6"><gtr:id>979F6FB8-AACC-4A25-9F7E-D0E620F050E6</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Wald</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/04ACC59F-B9C9-41D7-9BC8-E2AEFB1EAE4A"><gtr:id>04ACC59F-B9C9-41D7-9BC8-E2AEFB1EAE4A</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:otherNames>Paul</gtr:otherNames><gtr:surname>Bestwick</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/ECE44885-783A-4BD2-8E75-AE4870C11D89"><gtr:id>ECE44885-783A-4BD2-8E75-AE4870C11D89</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Wald</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1002158"><gtr:id>41A2F677-C750-499A-B879-A8BD91727112</gtr:id><gtr:title>Study of Child-Parent Screening for Familial Hypercholesterolaemia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1002158</gtr:grantReference><gtr:abstractText>Familial hypercholesterolaemia (FH) is an inherited condition that causes high blood cholesterol levels from birth and an extremely high risk of heart attack at a young age ? about one hundred times the usual risk before age 40. There are about 115,000 people with FH in the UK, but only about 15,000 have been identified, leaving about 100,000 children and adults undiagnosed and without life-saving cholesterol lowering treatment. This project aims to test a new screening strategy (child-parent screening), which for the first time, has the potential to systematically identify and treat nearly all cases of FH in the population.
Research published in 2007 showed that a cholesterol test undertaken between the age of 1 and 9 would identify about 90% of all FH cases, with only about 1 per 1000 unaffected children falsely classified as positive. Screening children when they attend for immunization at 1 to 2 years of age by combining a blood test and immunization in a single procedure has been shown to be a feasible and acceptable method of implementing this screening method. 
Each identified child has at least one affected parent (FH is inherited from parent to child) so screening children provides a means of identifying (and consequently treating) affected adults and children who have a high risk of a heart attack, before the onset of disease. There is now a need to test the accuracy and cost-effectiveness of child-parent screening in practice.
This award, if granted, would fund the screening, blood collection and data analysis in 10,000 children from 76 UK General Practices over a 3 year period. The immediate value of the results would be the formal scientific evaluation of this screening approach and the quantitative assessment of the measurements needed in screening. The longer term goal is the provision of a universal screening policy capable of identifying nearly all families with FH in the population and providing the opportunity to start treatment that could prevent about 800 deaths in young people each year.</gtr:abstractText><gtr:technicalSummary>A common cause of ischaemic cardiovascular disease in young adult life is the autosomal dominant inherited disorder Familial Hypercholesterolaemia (FH). There are about 100,000 undiagnosed people with FH in the UK population. Identifying affected individuals before the onset of disease is important because statin therapy, which lowers blood cholesterol levels, substantially reduces the risk of heart disease and stroke. 
A recent meta-analysis of observational studies has shown that a cholesterol measurement in children aged 1 to 9 identified about 90% of affected individuals with only about one per thousand unaffecteds falsely classified as positive. Screening newborns or adults was much less effective. The acceptability of screening children when they attend for routine immunization at 1 to 2 years of age has been demonstrated in a General Practice feasibility study. Each affected child will have one affected parent, identifiable as the one with the higher cholesterol, so screening children provides a means of identifying and treating both child and parent in a systematic manner. This has been called child-parent screening. There is now a need to test the predicted accuracy of child-parent screening in practice with a view to specifying an effective primary care based population screening policy. 
We propose a study of child-parent screening in 76 UK General Practices, administered through the MRC General Practice Research Framework using DNA analysis on all the children screened (10,000) as the confirmatory test. The results of the study will determine the screen positive rate based on total cholesterol, the detection rate and false positive rate based on DNA analysis and the cost-effectiveness and acceptability of a national screening programme in Britain. This will provide independent scientific evidence on the accuracy of child-parent screening and determine what modifications, if any, to the screening protocol are needed. The study will last three years and cost approximately #833,000.</gtr:technicalSummary><gtr:fund><gtr:end>2015-06-14</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-09-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>948205</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great Ormond Street Hospital (GOSH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Molecular Genetics</gtr:department><gtr:description>Great Ormond Street Hospital Department of Molecular Genetics</gtr:description><gtr:id>4C341A38-1C79-43EF-9F47-68048B688D15</gtr:id><gtr:impact>Awaited (recruitment complete)</gtr:impact><gtr:partnerContribution>DNA analyses</gtr:partnerContribution><gtr:piContribution>DNA analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Public Health and Policy</gtr:department><gtr:description>London School of Hygiene and tropical Medicine, Department of Health Economics</gtr:description><gtr:id>C656FC5E-E256-423F-8AA0-84854153D874</gtr:id><gtr:impact>Awaited</gtr:impact><gtr:partnerContribution>Health economics</gtr:partnerContribution><gtr:piContribution>Health economics</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research (NIHR)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR School of Primary Care Research Network</gtr:department><gtr:description>Primary Care Research Network</gtr:description><gtr:id>6D95225D-1B71-434D-8171-1B59D067E443</gtr:id><gtr:impact>Awaited (recruitment currently at 3000)</gtr:impact><gtr:partnerContribution>Primary care research infrastructure</gtr:partnerContribution><gtr:piContribution>Overall study design, coordination, implementation</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Nurse Practitioner Training</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>992AD733-1594-4A3F-8432-3FFD220FD284</gtr:id><gtr:impact>20 delegates who will take on FH screening in East of England

Training well received by nurse practitioners and PCRN staff</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Monthly recruitment reports</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>863A1EB0-4F97-4893-A8B0-767D0FD618D6</gtr:id><gtr:impact>Newsletters have been sent to 80 research nurses in about 80 general Practices across England, providing information of recruitment, the top 10 recruiters and useful clinical information regarding FH screening that is relevant to the conduct of the Child Parent Screening Study

This has created a high level of Nurse Engagement with the project.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NOCLOR Research Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4B668163-1B61-4410-A07D-0AE9DF653E47</gtr:id><gtr:impact>50 delegates attended and asked questions about how to get involved in research in primary care

Engaged people in rsearch</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Great Ormond Street Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>ECF03B89-D23C-49B8-8670-5BB2644ACDBB</gtr:id><gtr:impact>Keynote presentation on the Child-Parent Screening Study</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Specialist nurse training</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>80E9CEF3-9C16-4250-8122-17FC83FD69DA</gtr:id><gtr:impact>Lead to enrollment of new research practices in east of England</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keynote lecture - Heart UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6B18DFD4-2A3C-4C12-A904-301260BF47DC</gtr:id><gtr:impact>Heart UK annual conference</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Westminster FH Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EF16A6BA-C40C-4AE4-A640-31570CFEF176</gtr:id><gtr:impact>200 participants attended from experts to politicians followed by a dinner and talk in the House of Lords

Increased awareness and priority for FH screening in England</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FH Europe Network Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B04CDE4-30B5-48B7-841F-1D9E4F8B8775</gtr:id><gtr:impact>Keynote speaker about Child-Parent Screening for Familial Hypercholesterolemia</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National monthly Child-Parent Screening study (CPSS) newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>66D3C9E7-5F40-4B53-8FFB-F155723F7839</gtr:id><gtr:impact>Provide update on recruitment
Share clinical and research experiences across practices</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>43628</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Population and Systems Medicine Board (PSMB)</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002158/1</gtr:fundingRef><gtr:id>1E7D23C0-5BDC-4034-A8A8-2D142EF3C1A1</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A165BC43-F0EC-467A-8ED3-B163D10D27C0"><gtr:id>A165BC43-F0EC-467A-8ED3-B163D10D27C0</gtr:id><gtr:title>Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8e2d3b31901d6b9f25eb6a7d3366946"><gtr:id>d8e2d3b31901d6b9f25eb6a7d3366946</gtr:id><gtr:otherNames>Wald DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0912E223-993D-4EB3-8B92-BFA98C5750CE"><gtr:id>0912E223-993D-4EB3-8B92-BFA98C5750CE</gtr:id><gtr:title>The evaluation of cascade testing for familial hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a7c14465d73bf8241ea0a4903ebb32a5"><gtr:id>a7c14465d73bf8241ea0a4903ebb32a5</gtr:id><gtr:otherNames>Morris JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB8DB9AD-4746-48DD-B884-C368A8C230F0"><gtr:id>EB8DB9AD-4746-48DD-B884-C368A8C230F0</gtr:id><gtr:title>Child-parent screening for familial hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>The Journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8e2d3b31901d6b9f25eb6a7d3366946"><gtr:id>d8e2d3b31901d6b9f25eb6a7d3366946</gtr:id><gtr:otherNames>Wald DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3476</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EDE74252-5CE3-4439-B03E-5B0960B7559A"><gtr:id>EDE74252-5CE3-4439-B03E-5B0960B7559A</gtr:id><gtr:title>Child-Parent Familial Hypercholesterolemia Screening in Primary Care.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8e2d3b31901d6b9f25eb6a7d3366946"><gtr:id>d8e2d3b31901d6b9f25eb6a7d3366946</gtr:id><gtr:otherNames>Wald DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67F26359-E938-4E69-99F5-E0485631BDE6"><gtr:id>67F26359-E938-4E69-99F5-E0485631BDE6</gtr:id><gtr:title>Novel low density lipoprotein receptor variant linked to early onset acute myocardial infarction in a patient with familial hypercholesterolaemia.</gtr:title><gtr:parentPublicationTitle>JRSM open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/90ca68274af0d4a48051a6471fbdf2fa"><gtr:id>90ca68274af0d4a48051a6471fbdf2fa</gtr:id><gtr:otherNames>Bangash FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2054-2704</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FE3227A0-33AB-4EBC-811B-096661E2C879"><gtr:id>FE3227A0-33AB-4EBC-811B-096661E2C879</gtr:id><gtr:title>Child-Parent Familial Hypercholesterolemia Screening in Primary Care.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f02e9712cf847f443636c23444a82b8"><gtr:id>3f02e9712cf847f443636c23444a82b8</gtr:id><gtr:otherNames>Khera AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002158</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5C2ACE0A-A29E-4DCC-9F5A-B00BFAB172B9</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.4  Population screening</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>